Let’s start up with the current stock price of Arcutis Biotherapeutics Inc. (ARQT), which is $15.55 to be very precise. The Stock rose vividly during the last session to $15.76 after opening rate of $14.00 while the lowest price it went was recorded $13.90 before closing at $14.17.Recently in News on January 14, 2023, Arcutis Presents New Phase 2 Long-Term Data Showing Sustained Efficacy and Clearance for a Median of 10 Months with Roflumilast Cream in Adults with Chronic Plaque Psoriasis. During the open label trial, 57.1% of roflumilast-treated participants achieved Investigator Global Assessment (IGA) of clear or almost clear at any time in study; the median duration of clear or almost clear was 10 months (40.1 weeks). You can read further details here
Arcutis Biotherapeutics Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $15.76 on 01/19/23, with the lowest value was $12.81 for the same time period, recorded on 01/12/23.
Arcutis Biotherapeutics Inc. (ARQT) full year performance was -3.36%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Arcutis Biotherapeutics Inc. shares are logging -43.25% during the 52-week period from high price, and 21.39% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $12.81 and $27.40.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1226785 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Arcutis Biotherapeutics Inc. (ARQT) recorded performance in the market was 5.07%, having the revenues showcasing -18.07% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 926.62M, as it employees total of 147 workers.
Market experts do have their say about Arcutis Biotherapeutics Inc. (ARQT)
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 17.97, with a change in the price was noted -8.07. In a similar fashion, Arcutis Biotherapeutics Inc. posted a movement of -34.18% for the period of last 100 days, recording 792,693 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for ARQT is recording 0.73 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.73.
Technical breakdown of Arcutis Biotherapeutics Inc. (ARQT)
Raw Stochastic average of Arcutis Biotherapeutics Inc. in the period of last 50 days is set at 37.53%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 92.88%. In the last 20 days, the company’s Stochastic %K was 60.48% and its Stochastic %D was recorded 45.75%.
Bearing in mind the latest performance of Arcutis Biotherapeutics Inc., several moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 5.07%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -35.40%, alongside a downfall of -3.36% for the period of the last 12 months. The shares increased approximately by 14.93% in the 7-day charts and went up by -2.57% in the period of the last 30 days. Common stock shares were lifted by -18.07% during last recorded quarter.